Fluorescence-based biosensors: from concepts to applications

por Morris, May C
Publicado 2013

Shining Light on Protein Kinase Biomarkers with Fluorescent Peptide Biosensors

por Morris, May C.
Publicado 2022

Carbon nanotube biosensors

por Tîlmaciu, Carmen-Mihaela, Morris, May C.
Publicado 2015

Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics

por Heitz, Frederic, Morris, May Catherine, Divita, Gilles
Publicado 2009

Fluorescent Reporters and Biosensors for Probing the Dynamic Behavior of Protein Kinases

por González-Vera, Juan A., Morris, May C.
Publicado 2015

Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors

por Peyressatre, Marion, Prével, Camille, Pellerano, Morgan, Morris, May C.
Publicado 2015

Fluorescent Peptide Biosensor for Probing the Relative Abundance of Cyclin-Dependent Kinases in Living Cells

por Kurzawa, Laetitia, Pellerano, Morgan, Coppolani, J. B., Morris, May C.
Publicado 2011

A non-covalent peptide-based carrier for in vivo delivery of DNA mimics

por Morris, May C., Gros, Edwige, Aldrian-Herrada, Gudrun, Choob, Michael, Archdeacon, John, Heitz, Frederic, Divita, Gilles
Publicado 2007

Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells

por Harris, Rebecca, Yang, Ming, Schmidt, Christina, Royet, Chloe, Singh, Sarbjit, Natarajan, Amarnath, Morris, May, Frezza, Christian, Laman, Heike
Publicado 2022

Identification of Quinazolinone Analogs Targeting CDK5 Kinase Activity and Glioblastoma Cell Proliferation

por Peyressatre, Marion, Arama, Dominique Patomo, Laure, Arthur, González-Vera, Juan A., Pellerano, Morgan, Masurier, Nicolas, Lisowski, Vincent, Morris, May C.
Publicado 2020

Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth

por Crombez, Laurence, Morris, May Catherine, Dufort, Sandrine, Aldrian-Herrada, Gudrun, Nguyen, Quan, Mc Master, Gary, Coll, Jean-Luc, Heitz, Frederic, Divita, Gilles
Publicado 2009

Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth

por Bouclier, Celine, Simon, Matthieu, Laconde, Guillaume, Pellerano, Morgan, Diot, Sebastien, Lantuejoul, Sylvie, Busser, Benoit, Vanwonterghem, Laetitia, Vollaire, Julien, Josserand, Véronique, Legrand, Baptiste, Coll, Jean-Luc, Amblard, Muriel, Hurbin, Amandine, Morris, May C.
Publicado 2020

CDK6 is activated by the atypical cyclin I to promote E2F‐mediated gene expression and cancer cell proliferation

por Quandt, Eva, Masip, Núria, Hernández‐Ortega, Sara, Sánchez‐Botet, Abril, Gasa, Laura, Fernández‐Elorduy, Ainhoa, Plutta, Sara, Martínez‐Láinez, Joan Marc, Bru, Samuel, Munoz‐Torres, Pau M., Floor, Martin, Villà‐Freixa, Jordi, Morris, May C., Vidal, August, Villanueva, Alberto, Clotet, Josep, Ribeiro, Mariana P. C.
Publicado 2023